Lithium carbonate

Lithium carbonate Overview

Lithium carbonate (chemically designated as dilithium carbonate; chemical formula Li2CO3) is an inorganic alkali metal salt. Chemically, it belongs to the class of organic compounds known as organic carbonic acids and derivatives. Structurally, it consists of two monovalent lithium cations (Li+) ionically bonded to a central carbonate anion (CO3 2-). The lithium ion serves as the active pharmacological moiety, exhibiting monovalent cationic signaling properties similar to sodium and potassium ions within biological systems.

In psychiatric medicine, mood stabilization, and nephrology, Lithium carbonate functions as a mood stabilizer, antimanic agent, and neuroprotective compound (ATC code N05AN01 for lithium). Formulated as oral capsules, immediate-release tablets, extended-release tablets, and oral solutions (marketed under trade names such as Lithobid, Eskalith, Eskalith CR, and Lithane), it is indicated as a monotherapy for the acute treatment of manic and mixed episodes associated with Bipolar 1 disorder, as well as long-term maintenance therapy in Bipolar 1 disorder in adult and pediatric patients 7 years of age and older. Lithium possesses a narrow therapeutic index, requiring precise serum drug level monitoring to ensure efficacy while preventing severe systemic toxicity and chronic renal injury.

What Is Lithium carbonate and How Does It Work?

Lithium carbonate acts primarily through uncompetitive inhibition of inositol monophosphatase and glycogen synthase kinase-3 (GSK-3), leading to depletion of cellular myo-inositol and modulation of central neurotransmitter signaling cascades.

Its primary chemical, physiological, and psychiatric mechanisms include:

• Inositol Depletion Hypothesis: Lithium acts as an uncompetitive inhibitor of inositol monophosphatase (IMPase) and inositol polyphosphatase. By blocking the recycling of inositol phosphate into free myo-inositol, it decreases intracellular inositol trisphosphate (IP3) and diacylglycerol (DAG) signaling in overactive central neurons.
• Glycogen Synthase Kinase-3 (GSK-3) Inhibition: It directly competes with magnesium ions at the active catalytic site of GSK-3 alpha and GSK-3 beta, while also promoting inhibitory phosphorylation of GSK-3. Suppressing GSK-3 activity enhances neuroplasticity, cellular survival pathways, and circadian rhythm regulation.
• Neurotransmitter Transporter & Receptor Modulation: Lithium downregulates excitatory glutamate receptor signaling (including GluR3) while enhancing central GABAergic inhibitory neurotransmission and modulating monoaminergic (serotonin and dopamine) pathways.
• Renal Sodium Exchange Competition: In the renal tubule, monovalent lithium ions pass through epithelial sodium channels (ENaC) in the principal cells of the collecting duct. Intracellular accumulation of lithium impairs antidiuretic hormone (vasopressin) signaling, inhibiting aquaporin-2 channel insertion and impairing urinary concentrating ability.

Is Lithium carbonate FDA Approved?

Lithium carbonate was approved by the US FDA in March 1970 for the management of manic episodes of manic-depressive psychosis. Its current approval status is FDA Approved (March 1970).

What Is Lithium carbonate Used For?

• Treatment of acute manic and mixed episodes associated with Bipolar 1 disorder in patients 7 years of age and older.
• Maintenance therapy for Bipolar 1 disorder to reduce the frequency and severity of recurrent manic episodes in patients 7 years of age and older.
• Off-label treatment of major depressive disorder (as an augmenting agent), schizoaffective disorder, and cluster headache.

Before Taking Lithium carbonate: Contraindications & Precautions

Do not administer Lithium carbonate without strict monitoring in patients with severe renal impairment, severe cardiovascular disease, severe sodium depletion, or severe dehydration. Caution is advised when co-administering with drugs that alter renal sodium clearance, such as thiazide diuretics, NSAIDs, and ACE inhibitors, as they significantly increase serum lithium concentrations and toxicity risks.

Who Should Not Take Lithium carbonate?

• Patients with severe renal disease or advanced renal failure.
• Individuals with severe cardiovascular disease or sick sinus syndrome.
• Patients with severe sodium depletion, severe dehydration, or uncorrected Addison’s disease.
• Individuals with known hypersensitivity to lithium salts or formulation excipients.

Lithium carbonate, Pregnancy & Boxed Warning

Lithium carbonate carries a Boxed Warning regarding lithium toxicity related to its narrow therapeutic index. Lithium crosses the placental barrier. Exposure during the first trimester of pregnancy is associated with an increased risk of congenital cardiac cardiovascular malformations, specifically Ebstein’s anomaly (tricuspid valve displacement). Lithium should be used during pregnancy only if the potential benefit justifies the potential fetal risk. If used during pregnancy, serum lithium levels must be monitored frequently due to fluid volume shifts. Lithium is excreted in human breast milk; breastfeeding is generally not recommended during therapy.

Tell Your Doctor Before Taking Lithium carbonate

Inform your psychiatrist or physician if you have a history of kidney disease, thyroid dysfunction, heart disease, hyponatremia, psoriasis, or are taking blood pressure medications, diuretics, or anti-inflammatory drugs.

Lithium carbonate Dosage & Administration

Formulated as oral immediate-release capsules (150 mg, 300 mg, 600 mg), immediate-release tablets (300 mg), extended-release tablets (300 mg, 450 mg), and oral solution (8 mEq/5 mL).

Standard Lithium carbonate Dosing

• Acute Mania Dosing (Adults): Initial dosing is typically 900 mg to 1,800 mg/day orally given in divided doses (e.g., 600 mg three times daily or 900 mg extended-release twice daily), titrated to achieve a target serum lithium level between 0.8 and 1.2 mEq/L.
• Maintenance Bipolar Dosing (Adults): Target maintenance dosing is typically 900 mg to 1,200 mg/day orally in divided doses, titrated to achieve a steady-state serum level between 0.6 and 1.0 mEq/L.
• Pediatric Bipolar Dosing (Ages 7 and Older): Dosing is weight-based, titrated slowly to maintain serum levels between 0.6 and 1.2 mEq/L.

How Lithium carbonate Is Administered

• Take orally with food or milk to minimize gastrointestinal irritation.
• Swallow extended-release tablets whole; do not crush, chew, or break them.
• Maintain a consistent daily fluid intake (2 to 3 liters per day) and adequate, stable dietary salt consumption during therapy.

Lithium carbonate Clinical Efficacy & Safety Profile

Lithium carbonate remains a gold-standard mood stabilizer in psychiatric medicine, demonstrating proven efficacy in reducing acute manic symptoms, preventing bipolar relapse, and decreasing suicide risk in patients with mood disorders. Because of its narrow therapeutic window (0.6 to 1.2 mEq/L), levels above 1.5 mEq/L produce signs of toxicity, while levels above 2.0 mEq/L pose life-threatening hazards. Long-term therapeutic use requires vigilance regarding chronic renal complications, such as nephrogenic diabetes insipidus and chronic tubulointerstitial nephritis.

Lithium carbonate Side Effects & Safety Profile

Common adverse effects include fine hand tremor, polyuria, polydipsia, mild nausea, diarrhea, weight gain, fatigue, and muscle weakness. Serious adverse risks include acute lithium toxicity, nephrogenic diabetes insipidus, chronic kidney disease, hypothyroidism, hyperparathyroidism, cardiac arrhythmias, and serotonin syndrome. Holds an FDA Black Box Warning.

Common Lithium carbonate Side Effects

• Neurological & Autonomic: Fine hand tremor, fatigue, muscle weakness, memory impairment, and headache.
• Gastrointestinal & Metabolic: Mild nausea, vomiting, diarrhea, abdominal pain, increased thirst (polydipsia), increased urination (polyuria), and weight gain.

Serious Lithium carbonate Adverse Events

• Acute Lithium Toxicity: Moderate-to-severe neurotoxicity presenting with coarse hand tremors, ataxia, dysarthria, nystagmus, confusion, seizures, coma, and cardiac arrhythmias at serum levels exceeding 1.5 to 2.0 mEq/L.
• Nephrogenic Diabetes Insipidus & Renal Disease: Loss of renal urinary concentrating ability resulting in profound polyuria and dehydration; long-term use may cause chronic tubulointerstitial nephritis and reduced glomerular filtration rate.
• Endocrine Toxicity: Hypothyroidism, goiter, and primary hyperparathyroidism with hypercalcemia.
• Cardiovascular Toxicity: Sinus node dysfunction, T-wave flattening or inversion, severe bradycardia, and QTc prolongation.

Managing Lithium carbonate Side Effects

Monitor serum levels regularly and adjust doses accordingly. Ensure adequate hydration to manage polyuria. Manage fine tremors by reducing dosage or adding a beta-blocker (such as propranolol) if clinically indicated. Discontinue lithium and initiate emergency fluid resuscitation or hemodialysis if severe toxicity occurs.

Lithium carbonate Drug Interactions & What to Avoid

Lithium interactions relate primarily to alterations in renal sodium handling and clearance.

Lithium carbonate Drug-Drug Interactions

• Thiazide Diuretics (e.g., Hydrochlorothiazide): Increase renal proximal tubular sodium and lithium reabsorption, raising serum lithium levels by 24% to 40% and increasing toxicity risks.
• NSAIDs (e.g., Ibuprofen, Naproxen, Indomethacin): Decrease renal prostaglandin synthesis and reduce renal lithium clearance, leading to elevated serum lithium levels and toxicity.
• ACE Inhibitors & ARBs (e.g., Lisinopril, Losartan): Reduce aldosterone secretion and alter glomerular filtration, significantly elevating serum lithium concentrations.
• Serotonergic Drugs (e.g., SSRIs, SNRIs): Concomitant use increases the risk of serotonin syndrome.

Lithium carbonate, Food & Alcohol

Avoid low-sodium diets or sudden reductions in salt intake, as sodium depletion causes the kidneys to retain lithium, triggering toxicity. Maintain adequate daily water intake. Avoid alcohol consumption, which can worsen central nervous system depression and dehydration.

Lithium carbonate: Missed Dose, Overdose & Storage

Take missed doses as soon as remembered unless near the next dose. Overdose produces life-threatening neurotoxicity requiring hemodialysis. Store at room temperature (15°C–25°C).

Missed Dose of Lithium carbonate

Take the missed dose as soon as remembered. If it is within 6 hours of your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one.

Lithium carbonate Overdose & Emergency

Acute overdose causes severe neurological and cardiovascular collapse, marked by coarse tremors, severe ataxia, slurred speech, seizures, delirium, cardiac arrhythmias, renal failure, and coma. Emergency management involves airway support, vigorous intravenous isotonic saline hydration to promote lithium excretion, and hemodialysis for serum levels exceeding 2.5 mEq/L (or lower in the presence of severe clinical symptoms or renal failure).

How to Store Lithium carbonate

Store capsules and tablets at controlled room temperature between 15°C and 25°C (59°F to 77°F). Protect from excessive heat, light, and moisture. Keep containers tightly closed and strictly out of reach of children.

Lithium carbonate Patient Management & Monitoring

Requires routine serum drug monitoring, renal function testing, thyroid screening, and electrolyte checks.

Tests Before Starting Lithium carbonate

Baseline serum creatinine, estimated glomerular filtration rate (eGFR), blood urea nitrogen (BUN), serum electrolytes (especially sodium), thyroid function tests (TSH, free T4), calcium levels, complete blood count (CBC), baseline electrocardiogram (ECG), and pregnancy testing in females of childbearing potential.

Monitoring During Lithium carbonate Treatment

Draw blood samples for serum lithium levels 12 hours post-dose (trough level) every 1 to 2 weeks during initial titration until stable, then every 3 to 6 months during maintenance; monitor renal function (creatinine/eGFR) and thyroid function (TSH) every 3 to 6 months; monitor serum calcium and electrolytes annually.

Lithium carbonate Do’s and Don’ts

• Do drink plenty of fluids (8 to 12 glasses of water daily) and maintain a normal, consistent diet with adequate salt.
• Do have your blood drawn regularly to check your lithium levels as directed by your psychiatrist.
• Do contact your doctor immediately if you experience severe diarrhea, persistent vomiting, fever, or coarse hand shaking.
• Do not start a low-salt diet or take over-the-counter pain relievers (like ibuprofen) without consulting your doctor.
• Do not abruptly stop taking Lithium carbonate, as rapid withdrawal increases Bipolar relapse risk.

Frequently Asked Questions

References

• DrugBank Database – Lithium carbonate Clinical Profile (DB13987)
• Classyfire Database – Alkaline Earth Metal Chlorides / Inorganic Compounds Taxonomy Profile
• US FDA Prescribing Information – Metastron (Strontium-89 Chloride) Injection

Legal Disclaimer

The detailed medical and chemical information provided on this specific web page is intended strictly for educational and informational purposes regarding complex pharmacological mechanisms. It absolutely does not constitute professional medical advice, medical diagnosis, or specific treatment recommendations. Always consult a licensed healthcare provider before making any personal decisions regarding complex medical conditions, medication adjustments, or dietary changes.